|
LM_ID
|
Common Name
|
Systematic Name
|
Main class
|
Sub class
|
Mass
|
Formula
|
|
LMFA04010141
|
ent-7-epi-4-D4t-NeuroP
|
(R,E)-4-hydroxy-6-((1S,2S,5R)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid
|
Docosanoids [FA04]
|
Neuroprostanes [FA0401]
|
376.22
|
C22H32O5
|
|
LMFA04010268
|
ent-7-epi-4-E4c-NeuroP
|
(R,E)-4-hydroxy-6-((1R,2R,3S)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid
|
Docosanoids [FA04]
|
Neuroprostanes [FA0401]
|
376.22
|
C22H32O5
|
|
LMFA04010269
|
ent-7-epi-4-E4t-NeuroP
|
(R,E)-4-hydroxy-6-((1S,2S,3S)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid
|
Docosanoids [FA04]
|
Neuroprostanes [FA0401]
|
376.22
|
C22H32O5
|
|
LMFA04010166
|
ent-7-epi-7-D4c-NeuroP
|
(S,4Z,8E)-7-hydroxy-9-((1S,2R,5R)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid
|
Docosanoids [FA04]
|
Neuroprostanes [FA0401]
|
376.22
|
C22H32O5
|
|
LMFA04010163
|
ent-7-epi-7-D4t-NeuroP
|
(S,4Z,8E)-7-hydroxy-9-((1R,2S,5R)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid
|
Docosanoids [FA04]
|
Neuroprostanes [FA0401]
|
376.22
|
C22H32O5
|
|
LMFA04010294
|
ent-7-epi-7-E4c-NeuroP
|
(S,4Z,8E)-7-hydroxy-9-((1S,2R,3S)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid
|
Docosanoids [FA04]
|
Neuroprostanes [FA0401]
|
376.22
|
C22H32O5
|
|
LMFA04010291
|
ent-7-epi-7-E4t-NeuroP
|
(S,4Z,8E)-7-hydroxy-9-((1R,2S,3S)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid
|
Docosanoids [FA04]
|
Neuroprostanes [FA0401]
|
376.22
|
C22H32O5
|
|
LMFA04030005
|
AT-Resolvin D1
|
7S,8R,17R-trihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid
|
Docosanoids [FA04]
|
Resolvin Ds [FA0403]
|
376.22
|
C22H32O5
|
|
LMFA04030006
|
AT-Resolvin D2
|
7S,16R,17R-trihydroxy-4Z,8E,10Z,12E,14E,19Z-docosahexaenoic acid
|
Docosanoids [FA04]
|
Resolvin Ds [FA0403]
|
376.22
|
C22H32O5
|
|
LMFA04030008
|
AT-Resolvin D3
|
4S,11,17R- trihydroxy-5E,7E,9E,13Z,15E,19Z-docosahexaenoic-acid
|
Docosanoids [FA04]
|
Resolvin Ds [FA0403]
|
376.22
|
C22H32O5
|
|
LMFA04030007
|
AT-Resolvin D4
|
4S,5,17R-trihydroxy-6E,8E,10E,13E,15Z,19Z-docosahexaenoic acid
|
Docosanoids [FA04]
|
Resolvin Ds [FA0403]
|
376.22
|
C22H32O5
|
|
LMFA04030011
|
Resolvin D1
|
7S,8R,17S-trihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid
|
Docosanoids [FA04]
|
Resolvin Ds [FA0403]
|
376.22
|
C22H32O5
|
|
LMFA04030001
|
Resolvin D2
|
7S,16R,17S-trihydroxy-4Z,8E,10Z,12E,14E,19Z-docosahexaenoic acid
|
Docosanoids [FA04]
|
Resolvin Ds [FA0403]
|
376.22
|
C22H32O5
|
|
LMFA04030012
|
Resolvin D3
|
4S,10,17S-trihydroxy-5E,7E,9E,13Z,15E,19Z-docosahexaenoic acid
|
Docosanoids [FA04]
|
Resolvin Ds [FA0403]
|
376.22
|
C22H32O5
|
|
LMFA04030002
|
Resolvin D4
|
4S,5,17S-trihydroxy-6E,8E,10E,13E,15Z,19Z-docosahexaenoic acid
|
Docosanoids [FA04]
|
Resolvin Ds [FA0403]
|
376.22
|
C22H32O5
|